Sort
11,323 grants matching “glioblastoma”
Reorienting the Glioblastoma Microenvironment to Respond to Immunotherapy
$575,119Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2023 · NS
Deciphering heritability, plasticity and differentiation trajectories in gliomas via single-cell multi-omics
$575,064Mario Luca Suva · Massachusetts General Hospital · R01 · FY2021 · CA
Metabolic Therapy of GBM guided by MRS of hyperpolarized 13C-pyruvate
$575,027Lawrence D Recht · Stanford University · R01 · FY2014 · CA
Targeting Kif11 to Treat Glioblastoma Invasion and Proliferation
$574,526Steven S Rosenfeld · Mayo Clinic Jacksonville · R01 · FY2019 · NS
Targeting Amino Acid Metabolism in Glioblastoma
$574,427Jeremy N Rich · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · NS
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
$574,360David Akhavan · University Of Kansas Medical Center · R01 · FY2025 · CA
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
$574,360David Akhavan · University Of Kansas Medical Center · R01 · FY2023 · CA
Discovering And Modeling Genetic Events Driving Glioblastoma Pathogenesis
$574,086Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2011 · CA
Discovering And Modeling Genetic Events Driving Glioblastoma Pathogenesis
$573,914Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Targeting Go and Grow in Glioblastoma
$573,766Steven S Rosenfeld · Mayo Clinic Jacksonville · R01 · FY2020 · NS
Dissect governing factors for tumor stem cell dormancy in biomimetic vascular/GBM model
$573,350Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · NS
EGFRwt and EGFRvlll Dual-Specific Immunotoxin for Glioblastoma Multiforme
$573,030Darell D Bigner · Duke University · P01 · FY2013 · CA
Interleaved 1H/23Na imaging for invasive and proliferative phenotypes of brain tumors
$572,851Dewan Syed Fahmeed Hyder · Yale University · R01 · FY2023 · CA
NEXT GENERATION SEQUENCING ADD-ON-PHARMACOGENOMICS RESEARCH NETWROK (PGRN)
$572,671Elaine R Mardis · Washington University · U01 · FY2012 · GM
Targeting Tumors with NF1 Loss
$572,285Yolanda Sanchez · Dartmouth College · R01 · FY2015 · NS
The Antiproliferative Activities of Human Interferons
$571,998Kathryn Zoon · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma
$571,954Erik Sulman · New York University School Of Medicine · R01 · FY2021 · CA
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
$571,835Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2025 · NS
Fgl2 neutralizing therapy for inducing tumor specific brain resident immune memory against CNS tumor relapse
$571,813Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · NS
Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma
$571,444Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2025 · CA
Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma
$571,444Anna C Sorace · University Of Alabama At Birmingham · R01 · FY2023 · CA
Immuno-Cell Therapy for Brain Tumors
$571,443Xandra Owens Breakefield · Massachusetts General Hospital · R01 · FY2024 · NS
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
$570,541Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2024 · NS
A Novel Hsp90 Inhibitor as a Chemo and Radiosensitizer in Adults with Glioblastoma
$570,459Vinay K Puduvalli · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Nanoparticle MR Imaging of BBB Inflammation at High Tesla in CNS Tumors
$570,428Edward A Neuwelt · Oregon Health & Science University · R01 · FY2011 · NS